Immunicum AB (publ) Publishes the Outcome in the Share Issues and Raises SEK 351M

What we doOur approachPipelineTechnologyPublications
About usExecutive ManagementBoard of DirectorsScientific Advisory Board
News & eventsPress releasesEventsInterviews
Investors
Careers

Back
Immunicum AB (publ) Publishes the Outcome in the Share Issues and Raises SEK 351M
 6:00:30 PM

Keep reading
Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 2018Read